Department of Surgical Pathology, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo 143-8541, Japan.
Eur J Med Res. 2012 Mar 27;17(1):5. doi: 10.1186/2047-783X-17-5.
Although cardiac fibroma has been regarded as benign tumor, it presents various symptoms and may lead to death. Unfortunately, only a few studies have reported the epidemiology, embryology, and histopathology of the tumor, and the factors predicting poorer outcome are still obscured.
In July 2011 we searched for English and Japanese cases of cardiac fibroma using the PubMed and IgakuChuoZasshi databases. We then extracted and sampled raw data from the selected publications in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) style as much as was possible.
Details of a total of 178 patients with cardiac fibroma were retrieved. The mean age was 11.4 years (median: 2.8 years). Tumor sizes ranged from 8.0 to 150.0 mm (mean 53.1 mm). The left ventricle was found to be the most common site associated with the tumor at a rate of 57.3%, followed by the right ventricle, and interventricular septum. The highest mortality was found in patients with septal involvement (58.6%). In all, 111 patients survived among the 160 patients with a recorded outcome. A younger age of the patient at the time of diagnosis was associated with a decreased survival rate. In addition, a significant positive association was found between ages for patients younger than 17 years of age and the diameter of the tumor at the time of diagnosis (r = 0.341, P = 0.006).
Both the younger age of patients at the time of diagnosis and septal involvement can be regarded as factors significantly indicating a poor prognosis. Furthermore, our statistical analyses support the following hypotheses. First, the high ratio of tumor-to-heart size may generate low cardiac output and therefore lead to poor outcome. Second, the ratio of the sites where cardiac fibroma occurred corresponds with the ratio of the muscular weight of the cardiac chamber. Third, cardiac fibroma involving the interventricular septum more frequently induces conduction system disease.
尽管心脏纤维瘤被认为是良性肿瘤,但它会表现出各种症状,并且可能导致死亡。不幸的是,只有少数研究报告了肿瘤的流行病学、胚胎学和组织病理学,并且预测预后较差的因素仍不清楚。
我们于 2011 年 7 月使用 PubMed 和 IgakuChuoZasshi 数据库检索英文和日文的心脏纤维瘤病例。然后,我们尽可能按照系统评价和荟萃分析的首选报告项目(PRISMA)风格从选定的出版物中提取和采样原始数据。
共检索到 178 例心脏纤维瘤患者的详细资料。患者的平均年龄为 11.4 岁(中位数:2.8 岁)。肿瘤大小范围为 8.0 至 150.0mm(平均 53.1mm)。最常见的肿瘤部位是左心室,占 57.3%,其次是右心室和室间隔。间隔受累患者的死亡率最高(58.6%)。在有记录结局的 160 例患者中,有 111 例存活。诊断时患者年龄较小与生存率降低有关。此外,年龄小于 17 岁的患者年龄与诊断时肿瘤直径之间存在显著正相关(r = 0.341,P = 0.006)。
诊断时患者年龄较小和间隔受累均可视为预后不良的显著因素。此外,我们的统计分析支持以下假设。首先,肿瘤与心脏大小的比例较高可能导致心输出量降低,从而导致不良结局。其次,心脏纤维瘤发生的部位比例与心脏腔室的肌肉重量比例相对应。第三,室间隔受累的心脏纤维瘤更常引起传导系统疾病。